Alkahest Inc., a clinical stage biotechnology company focused on developing transformative therapies to treat age-related diseases, today announced presentations on GRF6021, GRF6019, and AKST4290 at the 14th International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD) on March 26 – 31, 2019 in Lisbon, Portugal.
March 26, 2019
· 3 min read